2.66
0.01 (0.38%)
0.01 (0.38%)
Upgrade to Real-Time
Afterhours (Closed)
Low
2.42
High
6.88
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| InflaRx NV | IFRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.01 | 0.38% | 2.66 | 19:52:21 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.64 | 2.52 | 2.68 | 2.68 | 2.65 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.53 | 2.66 | 0.13 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 536 | 189,261 | $ 2.63 | $ 496,841 | - | 2.42 - 6.88 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:52:21 | formt | 1,000 | $ 2.66 | USD |
Period:
Draw Mode:
InflaRx NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 117.54M | 44.19M | 39.93M | $ - | $ - | -1.53 | -2.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
InflaRx NV News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IFRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.57 | 2.73 | 2.42 | 2.65 | 149,256 | 0.09 | 3.5% |
| 1 Month | 2.98 | 3.10 | 2.42 | 2.78 | 124,770 | -0.32 | -10.74% |
| 3 Months | 3.74 | 3.86 | 2.42 | 3.02 | 243,871 | -1.08 | -28.88% |
| 6 Months | 5.87 | 6.38 | 2.42 | 4.03 | 311,308 | -3.21 | -54.68% |
| 1 Year | 4.99 | 6.88 | 2.42 | 4.43 | 341,978 | -2.33 | -46.69% |
| 3 Years | 33.00 | 53.10 | 2.17 | 6.15 | 555,195 | -30.34 | -91.94% |
| 5 Years | 15.19 | 53.10 | 2.17 | 6.65 | 463,881 | -12.53 | -82.49% |
InflaRx NV Description
| InflaRx NV is a clinical-stage biopharmaceutical company that is focused on applying proprietary anti-C5a technology to discover and develop specific inhibitors of the complement activation factor known as C5a. The lead product candidate of the company is IFX-1, which is developed for the treatment of Hidradenitis Suppurativa, a rare and chronic debilitating systemic inflammatory skin disease. The company's proprietary anti-C5a technology is an inflammatory mediator involved in the progression of a variety of autoimmune and other inflammatory diseases. It is also developing IFX-1 for the treatment of AAV, a life-threatening autoimmune disease associated with powerful inflammatory flares that impair kidney function and lead to fatal organ dysfunction. |
